ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2022
Zinzino group revenue in Q1 were unchanged compared with the previous year.
The revenue in March for Zinzino's sales markets decreased by 3% and amounted to SEK 118.1 (121.8) million. Faun Pharma's external sales increased by 87% and amounted to SEK 9.7 (5.2) million. Overall, the Group increased revenues by 1% to SEK 127.8 (127.0) million compared with the previous year.
The group revenue for Q1 2022 were unchanged compared with the first quarter last year and amounted to SEK 332.6 (333.4) million.
Revenues were distributed as follows:
| Regions, mSEK | 22-mar | 21-mar | Change | Q1 2022 | Q1 2021 | Change |
| The Nordics | 31.6 | 36.6 | -14% | 79.2 | 94.0 | -16% |
| Central Europe | 22.1 | 19.3 | 15% | 59.0 | 54.0 | 9% |
| East Europe | 31.5 | 31.8 | -1% | 83.5 | 81.0 | 3% |
| South & West Europe | 14.4 | 13.8 | 4% | 38.0 | 33.5 | 13% |
| The Baltics | 6.6 | 7.4 | -11% | 18.2 | 18.8 | -3% |
| North America | 5.4 | 4.8 | 13% | 14.0 | 14.6 | -4% |
| Asia-Pacific | 6.0 | 8.1 | -26% | 16.2 | 20.2 | -20% |
| Africa | 0.5 | 0.0 | 1.4 | 0.0 | ||
| Zinzino | 118.1 | 121.8 | -3% | 309.5 | 316.1 | -2% |
| Faun Pharma | 9.7 | 5.2 | 87% | 23.1 | 17.3 | 34% |
| Zinzino Group | 127.8 | 127.0 | 1% | 332.6 | 333.4 | 0% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 10:00 the 5th of April 2022.
Dag Bergheim Pettersen
CEO
+46 (0) 31 771 71 50
shares@zinzino.com
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.